We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Secukinumab 300 mg administered with an auto-injector ...
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the BD Intevia™ 1 mL two-step disposable autoinjector, a robust platform device combining ...
MAHWAH, N.J., Sept. 2, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch1 of Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose ...
Advances in large-volume injectors are enabling faster, more comfortable, at-home treatment. Patient-centric design, ...
BRAMPTON, Ontario--(BUSINESS WIRE)--Taro Pharmaceuticals Inc. has initiated a voluntary Type 1 recall to the patient level on six (6) lots of Taro-Zoledronic Acid Injection, 5 mg/100 mL in 100 mL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback